Shamburg News · 8-K filed Nov 9, 2026, 4:10 PM EST

GeneDx Reports Third Quarter 2026 Financial Results

WGS · GeneDx Holdings Corp.

  • Earnings
  • Financial statements
  • Materiality: high

GeneDx Holdings Corp. reported third quarter 2026 revenue of $123.1 million, up 5% year-over-year, and a GAAP net loss of $12.3 million, or $(0.41) per share. Adjusted net income was $8.6 million and adjusted diluted EPS was $0.28. The company reiterated full year 2026 revenue guidance of $475 to $490 million and set fourth quarter 2026 revenue guidance of $135 million.

Read the filing on EDGAR ↗

Source: SEC EDGAR, Form 8-K, Items 2.02, 9.01, accession 0001628280-26-072172.

Written from the filing by Shamburg Markets. Figures are as reported by the company.